1. Opioid use prior to surgery is associated with worse preoperative and postoperative patient reported quality of life and decreased surgical cost effectiveness for symptomatic adult spine deformity; A matched cohort analysis
- Author
-
Line, Breton, Bess, Shay, Gum, Jeffrey L, Hostin, Richard, Kebaish, Khaled, Ames, Christopher, Burton, Douglas, Mundis, Gregory, Eastlack, Robert, Gupta, Munish, Klineberg, Eric, Lafage, Virgine, Lafage, Renaud, Schwab, Frank, Shaffrey, Christopher, Smith, Justin S, and Group, International Spine Study
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Comparative Effectiveness Research ,Brain Disorders ,Clinical Research ,Chronic Pain ,Cost Effectiveness Research ,Pain Research ,Neurosciences ,Behavioral and Social Science ,Patient Safety ,Management of diseases and conditions ,7.1 Individual care needs ,Evaluation of treatments and therapeutic interventions ,6.4 Surgery ,Good Health and Well Being ,International Spine Study Group ,Adult spinal deformity ,Cost effectiveness ,Opioid ,Patient reported outcome measures ,Quality adjusted life years - Abstract
BackgroundPreoperative opioid is associated with poor postoperative outcomes for several surgical specialties, including neurosurgical, orthopedic, and general surgery. Patients with symptomatic adult spinal deformity (SASD) are among the highest patient populations reporting opioid use prior to surgery. Surgery for SASD has been demonstrated to improve patient reported quality of life, however, little medical economic data exists evaluating impact of preoperative opioid use upon surgical cost-effectiveness for SASD. The purpose of this study was to evaluate the impact that preoperative opioid use has upon SASD surgery including duration of intensive care unit (ICU) and hospital stay, postoperative complications, patient reported outcome measures (PROMs), and surgical cost-effectiveness using a propensity score matched analysis model.MethodsSurgically treated SASD patients enrolled into a prospective multi-center SASD study were assessed for preoperative opioid use, and divided into two cohorts; preoperative opioid users (OPIOID) and preoperative opioid non-users (NON). Propensity score matching (PSM) was used to control for patient age, medical comorbidities, spine deformity type and magnitude, and surgical procedures for OPIOID vs NON. Preoperative and minimum 2-year postoperative PROMs, duration of ICU and hospital stay, postoperative complications, and opioid use at one and two years postoperative were compared for OPIOID vs NON. Preoperative, one year, and minimum two-year postoperative SF6D values were calculated, and one- and two-year postoperative QALYs were calculated using SF6D change from baseline. Hospital costs at the time of index surgery were calculated and cost/QALY compared at one and two years postop for OPIOID vs NON.Results261/357 patients (mean follow-up 3.3 years) eligible for study were evaluated. Following the PSM control, OPIOID (n=97) had similar preoperative demographics, smoking and depression history, spine deformity magnitude, and surgery performed as NON (n=164; p>0.05). Preoperatively, OPIOID reported greater NRS back pain (7.7 vs 6.7) and leg pain (5.2 vs 3.9), worse ODI (50.8 vs 36.9), worse SF-36 PCS (28.8 vs 35.6), and worse SRS-22r self-image (2.3 vs 2.5) than NON, respectively (p
- Published
- 2022